Is Breast Massage Necessary to Find Sentinel Lymph Node?

Sponsor
Celal Bayar University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05663112
Collaborator
(none)
72
1
2
19.8
3.6

Study Details

Study Description

Brief Summary

Sentinel lymph node biopsy is important for staging in patients with breast cancer and changes the way of surgery. One of the most commonly used methods to find the sentinel lymph node during surgery is to apply blue dye around the areola and then search for the sentinel lymph node. Breast massage is recommended following administration of the blue dye. However, the necessity of this massage is controversial. In this study, investigators will try to find out whether massage of the breast after blue dye injection has any positive effect on finding the sentinel lymph node.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Sentinel lymph node biopsy
  • Procedure: Breast massage
  • Procedure: Blue dye injection
N/A

Detailed Description

This research is a prospective randomized study. Patients will be randomized by number-drawing method. Patients with BMI>30 and age>65 will be equally distributed to the experimental and active comparator arms. Under general anesthesia patients will be injected with 5 ml of isosulfan blue into the subareolar region. In one group, breast massage will be applied for 5 minutes. In the other group no massage will be applied. Surgical team will wait for a duration of 5 minutes for the self distribution of the blue dye.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
not necessary
Primary Purpose:
Diagnostic
Official Title:
Is Breast Massage Necessary to Find Sentinel Lymph Node After Isosulfan Blue Injection in Patients With Breast Cancer? A Prospective Randomized Study.
Actual Study Start Date :
Dec 6, 2021
Anticipated Primary Completion Date :
Jun 6, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm with massage

5 ml of isosulfan blue will be injected into the subareolar region. 5-minutes massage will be applied. Drug: Isosulfan Blue 5 ml

Procedure: Sentinel lymph node biopsy
Sentinel lymph node biopsy will be performed.

Procedure: Breast massage
Breast massage will be performed for a duration of 5 minutes.

Procedure: Blue dye injection
Isosulfan blue dye will be injected in the subareolar region of the breast

Experimental: Arm without massage

5 ml of isosulfan blue will be injected into the subareolar region. No massage will be applied. Drug: Isosulfan Blue 5 ml

Procedure: Sentinel lymph node biopsy
Sentinel lymph node biopsy will be performed.

Procedure: Blue dye injection
Isosulfan blue dye will be injected in the subareolar region of the breast

Outcome Measures

Primary Outcome Measures

  1. Sentinel lymph node detection rate [2 weeks]

    Participants will be followed until the pathology report is finalized

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • the diagnosis of breast cancer by biopsy

  • participants voluntarily participated in the clinical trial and signed informed consent

Exclusion Criteria:
  • had previous sentinel lymph node biopsy or axillary surgery

  • had neoadjuvant chemotherapy

  • had clinical hints of axillary lymph node metastasis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Celal Bayar University Manisa Yunusemre Turkey 45030

Sponsors and Collaborators

  • Celal Bayar University

Investigators

  • Study Director: Teoman Coskun, Prof., Celal Bayar University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Sezgi Erel, Research assistant, MD, Celal Bayar University
ClinicalTrials.gov Identifier:
NCT05663112
Other Study ID Numbers:
  • 20.478.486
First Posted:
Dec 23, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sezgi Erel, Research assistant, MD, Celal Bayar University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022